...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Bear

Posted on Zenith for general interest the company is publishing a poster at AACR June 22 it will then be available on co web

Share
New Message
Please login to post a reply